1. Silberstein EB, Alavi A, Balon HR, Becker D, Charkes ND, Clarke SEM, Divgi CR, Donohoe KJ, Delbeke D, Goldsmith SJ, Meier DA, Sarkar SD, Waxman AD, Society of Nuclear Medicine procedure guideline for scintigraphy for differentiated papillary and follicular thyroid cancer http://snmmi.files.cms-plus.com/docs/Scintigraphy%20for%20Differentiated%20Thyroid%20Cancer%20V3%200%20(9-25-06).pdf
2. Schlumberger M, Tubiana M, De Vathaire F, et al. Long term results of treatment of 283 patients with lung bone and metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1998;63:960–7.
3. Pacini F, Lippi F, Formica N, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med. 1987;28:1888–91.
4. Cailleux AF, Baudin E, Travagli JP, Schlumberger RM. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab. 2000;85:175–8.
5. Wartofsky L. Clinical utility of rh-TSH-stimulated thyroglobulin testing without scan in the follow-up of differentiated thyroid cancer. Denver: Program of the 83rd Annual Meeting of the Endocrine Society; 2000:P2–P535.